360° Coverage : Paid Constipation Clinical Trial Now Enrolling at Achieve...

2 Updates

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or...

Filed under: news

YouTube Videos Tweets

 
 
 

1 year ago

Paid Constipation Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Patients with Opioid-Induced Constipation Age 18-80

Aug 31 2013, 3:08am CDT | by PR.com

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Birmingham, AL, August 31, 2013 --(PR.com)-- *To see if you qualify for this Constipation Clinical Trial in Alabama, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and you may receive compensation for time and travel.

Study Design
This is a multicenter, double-blind, placebo-controlled, parallel-group study in participants with opioid-induced constipation who are taking opioid therapy for chronic non-cancer pain. Participants will be randomized in a 1:1 ratio to receive the new constipation drug or matching placebo. The study will consist of 3 periods: a screening period of up to 21 days, a 52-week double-blind treatment period, and a 4-week follow-up period.

Background & Rational
Patients who take opioids often suffer from constipation and associated gastrointestinal side effects (e.g., abdominal cramping, abdominal bloating, excess gas) for as long as they remain on opioid therapy. Based on the reported literature and previous clinical trials, these patients often suffer from constipation for many years thus requiring long-term management for this condition.

Opioid-induced constipation has a negative impact on a patient’s quality of life and, if not treated effectively, can lead to serious complications including obstipation and bowel perforation. Moreover, patients may discontinue opioids because of the associated constipation, thereby compromising their pain management and increasing the risk of systemic opioid withdrawal.

No drug has been approved as monotherapy for the treatment of constipation in patients taking opioid therapy for chronic non-cancer pain. Current treatment options are limited: they include stool softeners and laxatives; diet and exercise; and opioid dose-reduction, switching, or discontinuation. However, these treatments are often ineffective, associated with significant GI side effects, and burdensome to patients.

Primary Objective
Evaluate the safety and tolerability of this experimental constipation drug in human participants over 12 months, relative to a placebo.

Inclusion Criteria
To be eligible for enrollment, a subject must meet all of the following criteria before any study-related procedures are conducted:

Is able to understand and comply with the study procedures and voluntarily provide written informed consent
Is a man or woman aged 18 to 80 years, inclusive, at the time of Screening
Has a body weight of ≥ 45 kg and a body mass index (BMI) ≤ 45 kg/m
Has not achieved adequate relief with other treatments for constipation (e.g., laxatives)
Is taking a stable daily dose of opioids of ≥ 30-mg morphine-equivalent total daily dose (METDD) for chronic non-cancer pain for ≥ 30 days before Screening and expected to continue on a dose of ≥ 30-mg METDD for the duration of the study
Is taking opioids via oral, transmucosal, sublingual, or transdermal routes of administration (intrathecal opioids via pump are permitted provided they are taken in addition to a full opioid agonist meeting the METDD requirement)
Has constipation that is caused by the chronic use of opioids and has the following self-reported symptoms of constipation that a) have occurred in temporal association with and directly related to starting opioid therapy, b) have persisted since starting opioid therapy, and c) have been present for ≥ 2 months:

-- Decreased BM frequency and
≥ 1 other BM symptom (i.e., straining to pass a stool, lumpy hard stools or small pellets, or sense of incomplete evacuation after passing a stool)

If female, subjects must not be pregnant (confirmed via pregnancy test at Screening and Day 1), and must meet either Criterion (a) or Criterion (b) below:

Is not of childbearing potential: defined as postmenopausal (i.e., having no menses for ≥ 1 year without an alternative medical cause) or surgically sterile because of bilateral tubal ligation, bilateral oophorectomy, or hysterectomy
Is of childbearing potential, meets 1 of the following 4 criteria:
Is abstaining from sexual intercourse
Is using an insertable, injectable, transdermal, or combination oral contraceptive for ≥ 1 cycle before randomization through 30 days after the subject’s last dose of study medication
Is practicing a double-barrier method of birth control (if composed of a spermicide with either a condom or diaphragm)
Has a vasectomized partner (and is using a spermicide, condom, or diaphragm)

*Achieve Clinical Research conducts Phase II-IV Clinical Trials in Alabama. For more information about participating in a Constipation Clinical Study, please visit our website or contact us directly at (205) 380-6434.

Contact Information:
Achieve Clinical Research
Lashondra Cade
(205) 380-6434 320
Contact via Email
www.achieveclinical.com

Read the full story here: http://www.pr.com/press-release/513110

Press Release Distributed by PR.com

Source: PR.com

 
Update
2

Tweets

 
 

Don't miss ...

 

blog comments powered by Disqus

Latest stories

Pakistanis prominent winners at UK's Asian achievers awards
London, Sep 19 (IANS/RAY) Persons of Pakistani-origin emerged as prominent winners at the 2014 Asian Achievers Awards in Britain Friday while Sir Tejinder Singh Virjee, a professor of physics at Imperial College, London, headed the list of Indian-origin recipients.
 
 
Sierra Leone launches 'stay at home' drive to fight Ebola
Freetown, Sep 19 (IANS) Sierra Leone started a three-day "stay at home" campaign to raise awareness about the Ebola virus that has killed close to 500 people in the West African country.
 
 
Kenya to have security, health centre with EU's $65 help
Nairobi, Sep 19 (IANS) The European Union Friday said it will provide 65 million dollars to build a new regional security and health center in Kenya.
 
 
Pakistan says it values China's support for SCO membership
Islamabad, Sep 20 (IANS) Pakistan Friday said it appreciates China's support for the country's quest to become member of the Shanghai Cooperation Organization (SCO) as the group has agreed to expand its membership.
 
 
 

Latest from the Network

All will respect Scottish referendum's result: Queen Elizabeth
Edinburgh, Sep 19 (IANS) Queen Elizabeth II Friday said everyone in Britain will respect the result of the Scottish independence referendum, in which Scotland voted to stay part of the country. In a written statement...
Read more on Politics Balla
 
All will respect Scottish referendum's result: Queen Elizabeth
Edinburgh, Sep 19 (IANS) Queen Elizabeth II Friday said everyone in Britain will respect the result of the Scottish independence referendum, in which Scotland voted to stay part of the country. In a written statement...
Read more on Politics Balla
 
71 killed as army, rebels clash in Yemen
Sana'a, Sep 19 (IANS) Shiite Houthi rebels Friday clashed with the army and Sunni militia in Yemeni capital city of Sana'a for the second day, leaving 71 people killed, including 30 soldiers and eight civilians, Xinhua...
Read more on Politics Balla
 
Additional MH17 crash investigators return to Netherlands
The Hague, Sep 20 (IANS) The thirty additional researchers, who were sent to Kharkiv last week to investigate MH17 crash, returned to the Netherlands due to unstable security situation in eastern Ukraine, Dutch Prime...
Read more on Politics Balla
 
Iran, world powers start new round of nuclear talks
United Nations, Sep 20 (IANS) Iran and six major countries started a new round of talks towards a comprehensive agreement on its nuclear programme at the United Nations headquarters in New York Friday. The talks are...
Read more on Politics Balla
 
Pakistan says navy officers behind dockyard attack fled country
Islamabad, Sep 20 (IANS) Pakistan Defence Minister Khawaja Asif said Friday that two navy officers, who had been involved in a recent terrorist attack on navy targets, have fled the country. A navy officer and three...
Read more on Politics Balla
 
Pakistan says it values China's support for SCO membership
Islamabad, Sep 20 (IANS) Pakistan Friday said it appreciates China's support for the country's quest to become member of the Shanghai Cooperation Organization (SCO) as the group has agreed to expand its membership. On...
Read more on Politics Balla
 
Andie MacDowell and Jada Pinkett Smith join Magic Mike XXL
Andie MacDowell and Jada Pinkett Smith are joining the cast of 'Magic Mike XXL'. The 'Four Weddings and a Funeral' actress' has inked a deal for the sequel, though her role in the movie sequel hasn't yet been explained...
Read more on Movie Balla
 
Rian Johnson avoiding Star Wars 'responsibility'
Rian Johnson is trying not to feel too ''responsible'' for the 'Star Wars' franchise. The 40-year-old filmmaker is directing 'Star Wars: Episode VIII' and expect to helm Episode 'IX' admits that, when it comes to the...
Read more on Movie Balla
 
Michael Douglas prefers playing villains
Michael Douglas insists it's much more fun to play villains. The 69-year-old actor has had a varied career but admits he much prefers taking on the role of a villain and even claimed being an unlikeable character is...
Read more on Movie Balla